Global Thyroid Cancer Testing Market Size, Status and Forecast 2019-2025

SKU ID :QYR-13691817 | Published Date: 15-Jul-2019 | No. of pages: 94
Thyroid cancer is a type of cancer that occurs when abnormal cell begin to grow in thyroid gland, responsible for the excretion of thyroid hormones.
The global thyroid cancer testing is expected to show significant growth over the forecast period. Increasing prevalence of thyroid cancer, technological advancements are expected to boost the market of thyroid cancer testing.
In 2018, the global Thyroid Cancer Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Thyroid Cancer Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Thyroid Cancer Testing development in United States, Europe and China.

The key players covered in this study
Abbott Laboratories
F. Hoffmann-La Roche
Thermo Fisher Scientific
Siemens
Bio Rad Laboratories
GE Healthcare
Illumina
Koninklijke Philips
Toshiba Medical Systems
Agilent Technologies

Market segment by Type, the product can be split into
Imaging Tests
Blood Tests
Biopsy
Other

Market segment by Application, split into
Hospital Associated Labs
Independent Diagnostic Labs
Diagnostic Imaging Centers
Cancer Research Institutes
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Thyroid Cancer Testing status, future forecast, growth opportunity, key market and key players.
To present the Thyroid Cancer Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Thyroid Cancer Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
  • PRICE
  • $3900
    $7800
    Buy Now

Our Clients